Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Hepatorenal Syndrome: early-phase trial registry
2 of 6 indexed Hepatorenal Syndrome trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #2,866 of 28,707 conditions by registered trial count.
6 US clinical trials · 2 currently recruiting · #2,866 of 28,707 conditions by registered trial count
Hepatorenal Syndrome: 6 US clinical trials tracked, 2 recruiting.
Hepatorenal Syndrome is the subject of 6 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is Azienda Ospedaliera di Padova, running 1 of these trials.
Enrollment posture brief
Registry condition hepatorenal-syndrome
OPEN 2 | RECR 33% | LATE 1 | EARLY 2 | RANK #2866 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Adherence, Treatment (33% recruiting · 6 trials)
Hepatorenal Syndrome lists 2 open slots (33% of 6 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Hepatorenal Syndrome on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Hepatorenal Syndrome is recruiting below its size-band peers.
2 of 6 indexed trials (33.3%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Hepatorenal Syndrome research.
Azienda Ospedaliera di Padova accounts for 1 of 6 trials (16.7%). 6 distinct sponsors appear on at least one study for this condition label.
-
Most Hepatorenal Syndrome trials plan to enrol fewer than 100 people.
Median target enrolment is 50 among the 6 trials that report a genuine target (sentinel values excluded). 4 of those (66.7%) plan for fewer than 100 participants.
-
Hepatorenal Syndrome splits between interventional and observational designs.
4 interventional and 2 observational studies make up this index (66.7% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
6 total, page 1 of 1
A Retrospective Analysis of Outcomes in Patients with Hepatorenal Syndrome At Methodist Dallas Medical Center
Methodist Health System
NCT06095440
Initial Resuscitation for Acute Kidney Injury in Cirrhosis
Massachusetts General Hospital
NCT06525623
International Registry of Acute Kidney Injury in Cirrhosis: The GLOBAL AKI Project
Azienda Ospedaliera di Padova
NCT05387811
Terlipressin for HRS-AKI in Liver Transplant Candidates (INFUSE)
University of Pennsylvania
NCT04460560
A Study of OCE-205 in Participants With Cirrhosis With Ascites Who Developed Hepatorenal Syndrome-Acute Kidney Injury
Ocelot Bio
NCT05309200
Outcomes of Renal Function in Hepatorenal Syndrome (HRS) Determined By Comparison of Target Mean Arterial Pressure (MAP) of 65 - 70 Mmhg Versus ≥ 85 Mmhg
University of Louisville
NCT02789150
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 1 |
| Phase 3 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Hepatorenal Syndrome records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Hepatorenal Syndrome trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Hepatorenal Syndrome page
6 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 2 Hepatorenal Syndrome trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Azienda Ospedaliera di Padova sponsors the most Hepatorenal Syndrome trials on record, review their full trial history before evaluating a specific study. See Azienda Ospedaliera di Padova's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Hepatorenal Syndrome condition card totals 6 registered trials; most-linked intervention Crystalloids, albumin, vasoconstrictors, diuretics, renal replacement therapy; top US site state Texas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.